Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol
- PMID: 2952188
- DOI: 10.1002/bms.1200131203
Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol
Abstract
Oxcarbazepine (OCB) cannot be measured undecomposed by gas chromatography, not even when injected into a cooled, inert fused-silica capillary column. The bis-trimethylsilyl derivatives of the enol of OCB and of its main metabolite, 10-hydroxy-carbazepine (10-OH-CB), and the tris-trimethylsilyl derivative of carbazepine-10,11-trans-diol (CB-trans-diol) can be obtained easily at room temperature and are well suited for gas chromatographic and gas chromatographic/mass spectrometric analysis. Thermal decomposition to the substituted iminostilbene derivatives occurs only to the extent of a few per cent under the conditions described. Two gas chromatographic/mass spectrometric assays have been developed: one for the simultaneous quantification of OCB and 10-OH-CB, the other for CB-trans-diol. Both assays use carbazepine-10,11-cis-diol as the internal standard. Using 0.5 ml of plasma, limits of detection of 0.1, 0.1 and 1 ng/ml were obtained for OCB, 10-OH-CB and CB-trans-diol, respectively. CB-trans-diol is also the main metabolite of carbamazepine in patients under maintenance therapy. The kinetics of 15N-labelled CB-trans-diol derived from a single dose of (15N)carbamazepine has been measured in plasma and urine of patients and volunteers receiving (15N)carbamazepine in several studies.
Similar articles
-
Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother.Eur J Clin Pharmacol. 1988;34(3):311-3. doi: 10.1007/BF00540963. Eur J Clin Pharmacol. 1988. PMID: 3396622
-
Clinical pharmacokinetics of oxcarbazepine.Clin Pharmacokinet. 2003;42(12):1023-42. doi: 10.2165/00003088-200342120-00002. Clin Pharmacokinet. 2003. PMID: 12959634 Review.
-
Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma.J Chromatogr. 1985 Nov 29;345(1):67-76. doi: 10.1016/0378-4347(85)80136-5. J Chromatogr. 1985. PMID: 4086590
-
Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.Acta Neurol Scand. 1983 Sep;68(3):145-50. doi: 10.1111/j.1600-0404.1983.tb05340.x. Acta Neurol Scand. 1983. PMID: 6650125
-
Oxcarbazepine: pharmacokinetic interactions and their clinical relevance.Epilepsia. 1994;35 Suppl 3:S14-9. doi: 10.1111/j.1528-1157.1994.tb05939.x. Epilepsia. 1994. PMID: 8156974 Review.
Cited by
-
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.Pharmaceuticals (Basel). 2010 Jun 11;3(6):1909-1935. doi: 10.3390/ph3061909. Pharmaceuticals (Basel). 2010. PMID: 20640233 Free PMC article.
-
Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother.Eur J Clin Pharmacol. 1988;34(3):311-3. doi: 10.1007/BF00540963. Eur J Clin Pharmacol. 1988. PMID: 3396622
-
Clinical pharmacokinetics of oxcarbazepine.Clin Pharmacokinet. 2003;42(12):1023-42. doi: 10.2165/00003088-200342120-00002. Clin Pharmacokinet. 2003. PMID: 12959634 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous